Identifying the optimal therapeutics for patients with hormone receptor-positive, HER2-positive advanced breast cancer: a systematic review and network meta-analysis

INTRODUCTION: Hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-positive (HER2+) breast cancer is a distinct subtype with different prognosis and response to treatment. HER2-targeted therapy is currently recommended for patients with HR+/HER2+ advanced breast cancer. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Y., Xu, H., Han, Y., Wu, Y., Sa, Q., Wang, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172889/
https://www.ncbi.nlm.nih.gov/pubmed/37084609
http://dx.doi.org/10.1016/j.esmoop.2023.101216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172889/
https://www.ncbi.nlm.nih.gov/pubmed/37084609
http://dx.doi.org/10.1016/j.esmoop.2023.101216

Ejemplares similares